US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Myorisan

Reason Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product.

Akorn, Inc. NDC 61748-302-13 D-0647-2020
Class II · Moderate risk Terminated

Yeast Arrest

Reason cGMP violations

Wisconsin Pharmacal Company, LLC NDC 68093-0730-1 D-0781-2020
Class II · Moderate risk Terminated

AVKARE Ranitidine Tablets

Reason CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

AVKARE Inc. NDC 42291-725-25 D-0525-2020
Class II · Moderate risk Terminated

AVKARE Ranitidine Tablets

Reason CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

AVKARE Inc. NDC 42291-724-10 D-0524-2020
Class II · Moderate risk Terminated

Ranitidine Oral Solution

Reason CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.

Precision Dose Inc. D-1004-2020
Class II · Moderate risk Terminated

fentaNYL 550 mcg/55 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1274-50 D-0572-2020
Class II · Moderate risk Terminated

fentaNYL 1000 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1250-75 D-0571-2020
Class II · Moderate risk Terminated

fentaNYL 1500 mcg/30 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1180-79 D-0570-2020
Class II · Moderate risk Terminated

fentaNYL 2500 mcg/50 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1436-76 D-0569-2020
Class II · Moderate risk Terminated

fentaNYL 800 mcg/200 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1436-76 D-0568-2020
Class II · Moderate risk Terminated

fentaNYL 1250 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1444-05 D-0567-2020
Class II · Moderate risk Terminated

fentaNYL 1000 mcg/20 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1415-47 D-0566-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1103-36 D-0565-2020
Class II · Moderate risk Terminated

fentaNYL 400 mcg/200 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1441-76 D-0564-2020
Class II · Moderate risk Terminated

fentaNYL 2000 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1094-36 D-0563-2020
Class II · Moderate risk Terminated

fentaNYL 400 mcg/200 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1207-37 D-0562-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1108-36 D-0561-2020
Class II · Moderate risk Terminated

fentaNYL 250 mcg/5 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1098-44 D-0560-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1255-75 D-0559-2020
Class II · Moderate risk Terminated

fentaNYL 2750 mcg/55 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1100-50 D-0558-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1202-75 D-0557-2020
Class II · Moderate risk Terminated

fentaNYL 100 mcg/2 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1097-43 D-0556-2020
Class II · Moderate risk Terminated

fentaNYL 1000 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1092-36 D-0555-2020